RecruitingNot applicableNCT07030270
Rare condition
Neonatal acute respiratory distress syndrome
41
studies recruiting now
as of 7 Sept 2026
380
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
24 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07251790
Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study
RecruitingNCT07550218
Surfactant Administration Methods in Preterm Infants With RDS: A Swedish Cohort Study
RecruitingNot applicableNCT07442669
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
RecruitingNot applicableNCT06421506
Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 41 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Neonatal acute respiratory distress syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Neonatal acute respiratory distress syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (SFTPB, ABCA3).
Treatments being studied
40 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Pirfenidone (Esbriet)
Phase 3Dexamethasone (Aeroseb-dex)
Phase 3Cisatracurium Besylate (Cisatracurium besylate)
Phase 3Ravulizumab (Ultomiris)
Phase 3Oxygen (Medicinal oxygen air liquide sante)
Phase 3Hydroxychloroquine
Phase 3Poractant Alfa (Curosurf)
Phase 3Transcrocetin (Transcrocetin component of leaf-4l6715 ate)
+ 32 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).